Theonys

Cambridge, United States

Theonys is harnessing the power of tRNA to pioneer an entirely new class of genomic medicines.

$2.9M raised

Aug 2022

Venture - Series Unknown

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Theonys

How much funding has Theonys raised?

Theonys has raised $2.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2022.

Where is Theonys headquartered?

Theonys is headquartered in Cambridge, United States.

What does Theonys do?

Theonys is harnessing the power of tRNA to pioneer an entirely new class of genomic medicines.

What stage is Theonys at?

Theonys is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 25, 2022.

MLA

"Theonys — Funding & Investors." VCBacked, August 25, 2022, https://www.vcbacked.co/company/theonys. Accessed July 3, 2026.

APA

VCBacked. (2022). Theonys — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/theonys

Wikipedia (cite web)

{{cite web |title=Theonys — Funding & Investors |url=https://www.vcbacked.co/company/theonys |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 25, 2022.